Search Within

Department of Medicine

Formats
  1. Journal Article (19620)
  2. Meeting Abstract (16084)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22367)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10658)
  5. Survivorship Research (9352)
  6. Division of Subspecialty Medicine (7560)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1158)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39711)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of age, prior therapies, and subsequent transplant on long-term outcomes of adults with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3
    Meeting Abstract

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of patients with AML with an exceptional response to ivosidenib
    Meeting Abstract

    Watts, J. M.; Patel, P. A.; Choe, S.; Bai, X.; Marchione, D. M.; Stein, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world (RW) use of venetoclax (VEN) in patients (pts) with acute myeloid leukemia (AML) in a US RWE database (COTA)
    Meeting Abstract

    Zeidan, A. M.; Hernandez D. L.; Hodzic, S.; Owusu, H. F.; Pathak, D.; Zhou, S. Q.; Stein, E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Oncologists' receipt of pharmaceutical industry payments and use of non-recommended and low-value cancer care services
    Meeting Abstract

    Mitchell, A. P.; Dusetzina, S. B.; Mishra Meza, A.; Trivedi, Niti U.; Bach, P. B.; Winn, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of obecabtagene autoleucel (obe-cel, AUTO1), a fast-off rate CD19 CAR, in relapsed/refractory adult B-cell acute lymphoblastic leukemia (r/r B-ALL): Top line results of the pivotal FELIX study
    Meeting Abstract

    Roddie, C.; Sandhu, K. S.; Tholouli, E.; Shaughnessy, P.; Barba, P.; Guerreiro, M. N.; Yallop, D.; Abedi, M.; Chaganti, S.; Ghobadi, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Big data in oncology: Challenges and solutions
    Meeting Abstract

    Shah, N. J.; Bahadur, N.; Niederhausern, A.; Insinga, A.; Shah, I.; West, G.; Ahmad, H.; Martin, S.; Watson, A.; Nichols, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Commercial vs. Medicaid insurance and use of high-priced anticancer treatments
    Meeting Abstract

    Mitchell, A. P.; Kinlaw, A. C.; Peacock Hinton, S.; Dusetzina, S. B.; Sanoff, H. K.; Lund, J. L.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Updated results from a phase 2 study of the oral vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor rivoceranib for recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC)
    Meeting Abstract

    Kang, H.; Ahn, M. J.; Keam, B.; Bowles, D. W.; Wong, D. J. L.; Ho, A. L.; Kim, S. B.; Worden, F. P.; Yun, T.; Jang, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC)
    Meeting Abstract

    Cabanillas, M. E.; Lin, J. J.; Brose, M. S.; McDermott, R. S.; Almubarak, M.; Bauman, J. R.; Casanova, M.; Kummar, S.; Lee, S. H.; Leyvraz, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
    Meeting Abstract

    Desilets, A.; Pfister, D. G.; Wong, W.; Sherman, E. J.; Fetten, J. V.; Hung, K. W.; Dunn, L.; Ho, A. L.; Michel, L. S.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save